A role for GPx3 in activity of normal and leukemia stem cells by Herault, O. et al.
 
Repository of the Max Delbrück Center for Molecular Medicine (MDC) 
in the Helmholtz Association  
 
http://edoc.mdc-berlin.de/12349 
 
 
 
 
 
A role for GPx3 in activity of normal and leukemia stem cells 
 
Herault, O. and Hope, K.J. and Deneault, E. and Mayotte, N. and Chagraoui, J. and Wilhelm, B.T. 
and Cellot, S. and Sauvageau, M. and Andrade-Navarro, M.A. and Hebert, J. and Sauvageau, G. 
 
 
 
 
 
This is a copy of the final article, which was first published online on 16 April 2012 and in final 
edited form in: 
 
Journal of Experimental Medicine 
2012 MAY 07 ; 209(5): 895-901 
doi: 10.1084/jem.20102386  
 
Publisher: Rockefeller University Press 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2012, Herault et al. This article is distributed under the terms of an Attribution–Noncommercial–
Share Alike–No Mirror Sites license for the first six months after the publication date 
(see http://www.rupress.org/terms).  
 
After six months it is available under a Creative Commons License 
(Attribution–Noncommercial–Share Alike 3.0 Unported license, as described 
at http://creativecommons.org/licenses/by-nc-sa/3.0/). 
The Rockefeller University Press $30.00
J. Exp. Med. Vol. 209 No. 5 895-901
www.jem.org/cgi/doi/10.1084/jem.20102386
895
Brief Definit ive Report
The cancer stem cell (CSC) hypothesis postulates 
that most cancers are heterogeneous in their cellu-
lar constituents and that self-renewal potential is 
restricted to a subset of cells within each tumor. 
The frequency of CSC appears to vary consider-
ably between tumors and also in time within a 
given cancer. CSCs are best described in human 
leukemia in which the leukemia stem cells (LSCs) 
can be prospectively isolated and transmit the dis-
ease when introduced in immuno-compromised 
mice (Lapidot et al., 1994). A detailed understand-
ing of the molecular bases that regulate LSC self-
renewal is lacking. Growing evidence indicates 
that although certain regulators of self-renewal 
(e.g., Bmi1) are shared between normal cells and 
LSCs (Lessard and Sauvageau, 2003), others (e.g., 
NF-kB and Wnt/-catenin) are more specific to 
LSC (Guzman et al., 2002; Wang et al., 2010).
Variation in oxidative stress has been as-
sociated with changes in self-renewal poten-
tial of normal hematopoietic stem cells (HSCs; 
Shao et al., 2011). By analogy, oxidative stress 
may also affect LSC self-renewal but the ex-
perimental evidence supporting this possibility 
remains scarce (Konopleva and Jordan, 2011). 
Using a series of recently characterized mouse 
acute myeloid leukemia (AML; Wilhelm et al., 
2011) in which the LSC frequency varied from 
1 in 100–350 to 1 in 1.4 cells, we now show that 
Gpx3, a reactive oxygen species (ROS) detoxify-
ing enzyme, determines the activity of normal 
cells and LSCs, extending the function of oxida-
tive stress to regulation of LSC biology in vivo.
RESULTS AND DISCUSSION
High LSC frequency leukemia  
expresses elevated GPx3
We reasoned that comparative mRNA pro-
filing of FLA2 (LSC at 70% or 1 in 1.4 cells; 
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The determinants of normal and leukemic stem cell self-renewal remain poorly characterized. 
We report that expression of the reactive oxygen species (ROS) scavenger glutathione peroxi-
dase 3 (GPx3) positively correlates with the frequency of leukemia stem cells (LSCs) in 
Hoxa9+Meis1-induced leukemias. Compared with a leukemia with a low frequency of LSCs,  
a leukemia with a high frequency of LSCs showed hypomethylation of the Gpx3 promoter 
region, and expressed high levels of Gpx3 and low levels of ROS. LSCs and normal hematopoi-
etic stem cells (HSCs) engineered to express Gpx3 short hairpin RNA (shRNA) were much less 
competitive in vivo than control cells. However, progenitor cell proliferation and differentia-
tion was not affected by Gpx3 shRNA. Consistent with this, HSCs overexpressing Gpx3 were 
significantly more competitive than control cells in long-term repopulation experiments, and 
overexpression of the self-renewal genes Prdm16 or Hoxb4 boosted Gpx3 expression. In 
human primary acute myeloid leukemia samples, GPX3 expression level directly correlated with 
adverse prognostic outcome, revealing a potential novel target for the eradication of LSCs.
© 2012 Herault et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months it 
is available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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levels of an additional 170 potential regulators of stem cell 
activity analyzed (Supplemental Text). In accordance with 
the Gpx3 overexpression in FLA2, 14/14 tested CpG se-
quences in the Gpx3 promoter region were methylated in 
FLB1 and hypomethylated in FLA2 cells (Fig. 1 B). Higher 
expression of Gpx3 in FLA2 compared with FLB1 cells re-
sulted in increased protein levels (Fig. 1 C) and elevated glu-
tathione peroxidase activity (1,773 ± 127 nmol/min/ml and 
1,077 ± 60 nmol/min/ml, respectively; Fig. 1 D).
Flow cytometric comparison of the ROS indicator dichlo-
rodihydrofluorescein diacetate (H2DCFDA) fluorescence re-
vealed a relative reduction in ROS levels in FLA2 compared 
FLB1 leukemia (Fig. 2 A), and confocal analysis confirmed 
these results (Fig. 2 B). Elevated ROS levels also result in lipid 
peroxidation and formation of malondialdehyde (MDA) pro-
tein adducts, and Western blot analyses demonstrated increase 
in MDA levels in FLB1 compared with FLA2 cells (Fig. 2 C).
Members of the FoxO subfamily regulate intracellular ROS 
through transcriptional up-regulation of antioxidative enzymes 
Wilhelm et al., 2011) to the phenotypically similar FLB1 
(0.3% LSC) might identify genes uniquely associated with 
LSC activity (Fig. 1 A). Microarray-based global gene 
expression profiling identified very few genes—besides some 
sex chromosome and immunoglobulin light chain (IgK-C) 
genes—as having differential expression between these two 
leukemia specimens. After excluding the sex chromosome 
genes because of the male and female origin of FLA2 and 
FLB1, only 16 probe sets exhibited significant changes of sig-
nal for a false discovery rate of 2.71% (Table S1). In particu-
lar, qRT-PCR confirmed a two- to threefold up-regulation 
of antioxidant enzyme glutathione peroxidase 3 (Gpx3) in 
FLA2 compared with FLB1 (Supplemental Text).
Because redox metabolism has been implicated in normal 
HSC self-renewal (Ito et al., 2004, 2006; Tothova et al., 
2007), we compared the mRNA levels of other antioxidant 
enzymes implicated in ROS detoxification. In contrast to 
Gpx3, most of these genes are expressed at comparable levels 
in FLA2 and FLB1 cells (Fig. 1 A), which also express similar 
Figure 1. GPx3 is overexpressed in FLA2 cells. (A) Plot depicting proportions of overexpressed (red points) and underexpressed (green points) genes 
in FLA2 (high LSC frequency) compared with FLB1 cells (low LSC frequency). RNA isolated from BM cells of leukemic mice (n = 3 per group) was reverse 
transcribed, and cDNA was hybridized on Affymetrix Mouse Genome 430A microarrays. The stringency of the false discovery rate for the GCRMA-normalized 
data was adjusted using the SAM software (top left). The antioxidant enzymatic pathway and putative function of each enzyme (top right) is shown. 
Analyses of antioxidant enzyme expression in FLA2 (high LSC frequency) and FLB1 cells (low LSC frequency) are shown. Results of qRT-PCR assays are 
presented as FLB1/FLA2 expression ratios (mean ± SD, n = 3). Ct values (versus Actb) shown below indicate expression levels of each transcript (bottom). 
(B) Methylation status of the CpG island in the promoter region of Gpx3 as determined by sequencing HSO3-treated gDNA. Each row represents one leu-
kemic mouse (n = 5 per group). Open circle, nonmethylated CpG; closed circle, methylated CpG. (C) Western blot analysis of GPx3 protein levels in FLA2 
and FLB1 cells. -Tubulin was used as loading control. Black lines indicate that intervening lanes were spliced out. (D) Quantitation of the GPx (glutathi-
one peroxidase) activity in spleens of FLA2 and FLB1 leukemic mice (n = 6, two experiments) reveals significant increase (P = 0.0277) in splenic GPx activ-
ity of FLA2 mice. Spleens of FLA2 and FLB1 leukemic mice had similar weights (239 ± 12 and 227 ± 18 mg in FLA2 and FLB1 mice, respectively; mean ± SD,  
n = 19) and comparable leukemic blast infiltrations (Fig. S1).
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in these experiments ranged from 42 to 66%, and because 
FLA2 cells poorly survive cell sorting, untransduced leukemia-
initiating cells were co-transplanted together with transduced 
cells. This resulted in competitive repopulation experiments 
in which both the GFP+ shRNA (either Luciferase or Gpx3)-
transduced and GFP untransduced FLA2 cells contributed 
to leukemia development in vivo. To assess the effect of 
shRNA treatment on relative contribution of each cell 
population to clinical leukemia 19 d later, we compared 
changes in proportions (Fig. 3 B, left) and mean fluorescence 
intensity (MFI; Fig. 3 B, middle and right) of GFP+ FLA2 
cells at two different time points (t = 0 and 19 d). The de-
crease in proportion of GFP+ FLA2 cells contributing to 
fulminant leukemia (19 d) below the values determined for 
the initial transplant was at least twofold higher after Gpx3 
knockdown compared with shLuc control (Fig. 3 B, left). 
Moreover, the shGpx3-infected FLA2 cells remaining at day 
(Kops et al., 2002; Tothova et al., 2007). FoxO-deficient 
HSCs were reported to overexpress several antioxidant enzymes 
such as Sod1, Sod3, Prdx6, and Gpx4, but not Gpx3 (Tothova 
et al., 2007). FLA2 and FLB1 leukemias expressed comparable 
levels of Foxo3a, Foxo4, and Foxo6, whereas Foxo1 was not 
expressed (Supplemental Text), indicating that FoxO induction 
is likely not responsible for differential ROS (Supplemental 
Text) and suggesting that the only differentially expressed anti-
oxidant enzyme GPx3 may be responsible for the decreased 
ROS observed in FLA2 leukemia.
GPx3 promotes LSC in vivo competitiveness
Correlation between GPx3 levels and LSC frequency could 
reflect functional dependence of LSC on this enzyme. We 
exploited retroviruses encoding short hairpin RNAs (shRNAs) 
and IRES-GFP reporter to explore the in vivo activity 
of FLA2 cells after GPx3 knockdown (Fig. 3 A). Gene transfer 
Figure 2. The ROS level is decreased in FLA2 cells. (A) Intracellular ROS levels in FLA2 and FLB1 evaluated by flow cytometry using H2DCFDA probe 
immediately after extracting marrow from leukemic mice. Open histograms, DMSO (vehicle control); filled histograms, H2DCFDA. (B) Confocal microscopy 
of FLA2 and FLB1 cells stained with H2DCFDA. 20 cells of each leukemia were randomly chosen and classified according to H2DCFDA fluorescence. The 
corresponding phase-contrast pictures are presented. (C) Western blot of MDA-modified protein adducts in FLA2 and FLB1 cells. H2O2-treated FLA2 cells 
were used as a positive control and -tubulin as a loading control. Asterisks indicate major MDA protein adduct species. The dotted line shows margins  
of two blots shown in a merged image.
Figure 3. Gpx3 depletion decreased LSC 
competitiveness. Left: effect of the RNAi-
mediated depletion of Gpx3 on the competi-
tiveness of FLA2 leukemic cells. 2 × 105 fresh 
FLA2 BM cells were co-cultured with shLuc or 
shGpx3 retrovirus-producing GP+E-86 cells. 
After infection (d0), cells were partitioned 
between flow cytometric analysis of GFP+ 
frequency and transplantation of unsorted 
cells into sublethally irradiated recipients 
(shLuc, n = 12; shGpx3, n = 16). Contribution 
of GFP+ (shRNA-transduced) cells to leukemia 
was determined on day 19. Results are shown 
as normalized values: the GFP+ frequency in inoculum was considered 100% (dotted line, d0), and the day 19 GFP+ frequency was calculated as a per-
centage of that value. Horizontal bars represent mean values determined for each experimental group. Middle: day 19 MFIs of GFP+ cells in recipients of 
shLuc- and shGpx3-infected FLA2 leukemic cells. The dotted line represents MFI of GFP+ cells in shLuc and shGpx3 inocula. Horizontal bars represent 
mean values determined for each experimental group. Right: GFP fluorescence intensity in representative recipients of shLuc- or shGpx3-infected FLA2 
cells. The inset demonstrates comparable MFI GFP fluorescence in shLuc and shGpx3 inocula. *, P = 0.0037 and P = 0.0015, respectively (Wilcoxon’s test).
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19 displayed a significant reduction in MFI of GFP compared 
with controls (Fig. 3 B, middle and right). These results indi-
cate that GFPhigh cells were selectively depleted (Fig. 3 B, 
right, inset), and suggest that Gpx3 is critical for the competi-
tiveness of LSCs.
We quantified GPX3 expression in 48 acute myeloid 
leukemia patients categorized into cytogenetically and 
molecularly defined risk subgroups designated as favorable, 
intermediate, and adverse (Mrózek et al., 2007). Within the 
AML samples, expression of GPX3 increased with the sever-
ity of disease, and the highest expression levels were associ-
ated with adverse risk group of patients (P = 0.019; Fig. 4). 
The worst clinical outcomes were thus observed in AML en-
riched for phenotypically defined LSC (van Rhenen et al., 
2005) and high GPX3 levels, indicating that GPX3 may be 
relevant for human leukemia.
Gpx3 influences normal HSC activity
Adult BM-derived HSCs are less proliferative than their fetal 
liver (FL)–derived counterparts (Rebel et al., 1996). Quantita-
tive RT-PCR (qRT-PCR) assays revealed that HSC isolated 
from BM of 3- and 4-wk-old mice express 39- to 6-fold, 
respectively, lower Gpx3 levels than HSC sorted from embry-
onic day 14.5 (E14.5) FL (Fig. 5.A), suggesting a correlation 
between Gpx3 expression and HSC activity. Interestingly, 
Gpx3 levels were also elevated in BM HSC/progenitor cells 
Figure 4. GPX3 expression in marrow samples from AML patients 
classified into cytogenetic and molecular risk subgroups. Expression of 
GPX3 was quantified by qRT-PCR (Ct method versus GAPDH and HPRT) in 
marrow leukemic cells (leukoblasts > 95%) from AML patients and FACS-
sorted marrow CD34+ cells from healthy volunteers. Results are presented as 
relative expression (RQ = 2Ct) of GPX3 versus normal marrow CD34+ cells 
(dotted line, Ct = 10.10 ± 0.58, n = 5 for normal marrow CD34+ cells). Hori-
zontal bars represent mean GPX3 levels determined for individual risk sub-
group. *, P = 0.0192 (adverse versus favorable risk subgroups; Wilcoxon’s test).
Figure 5. Gpx3 regulates the self-renewal capacity of normal HSCs. (A) Gpx3 expression in HSC isolated from 3- or 4-wk-old mice (KLS SLAM cells) com-
pared with HSC from E14.5 FL (SLAM Sca+Mac1+) cells. Mean ± SD, n = 2. (B) Empty vector (n = 3), Prdm16 (n = 4), Hoxb4 (n = 3), NA10HD (n = 4), and Klf10 (n = 3) 
were overexpressed in LinCD150+CD48 sorted BM cells as previously described (Deneault et al., 2009). Gpx3 mRNA was evaluated by qRT-PCR. (C) 5-FU–treated 
BM cells were transduced with shLuc or shGpx3. Gpx3 mRNA was evaluated by qRT-PCR in four experiments (left). CFC output was assessed in two experiments 
(right; mean ± SD; n = 8). GFP+ cells were shRNA-transduced cells. (D) Evaluation of short-term and LTR ability of KLS CD150+CD48Ly5.1+ BM cells expressing 
shLuc or shGpx3 in competitive transplantations into congenic Ly5.2 mice. Results are presented from both peripheral blood (PB) and BM, and represent mean ± 
SEM at the indicated time points for 8 mice per group. The level of gene transfer was near 100% (right) and Gpx3 silencing was obtained in all experiments (n = 4). 
Two independent shGpx3 constructs (#5 and #6) were used. (E) Gpx3, Hoxb4, or empty vector was overexpressed in BM KLS CD150+CD48 sorted cells (as described 
in Deneault et al., 2009), cells were expanded for 7 d ex vivo, and competitive transplantations in Ly5.2 congenic mice were performed. Results are shown as mean ± 
SEM of peripheral blood reconstitution at the indicated time points for three mice per group in five experiments. *, P = 0.0015 (Wilcoxon’s test). (F) Southern blot 
analyses of Gpx3 proviral integrations in DNA isolated from BM from mice reconstituted 20 wk earlier with Gpx3-transduced cells. n = 2 experiments, three mice 
per experiment. (G) Analysis of differentiation potential of vector or Gpx3-transduced cells in vivo. Blood cells were collected from recipients transplanted 20 wk 
earlier and stained with antibodies specific for B, T, and myeloid cells (B220, CD3, and CD11b, respectively). Values are mean ± SD (vector: n = 5; Gpx3, n = 2).
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Owusu-Ansah et al., 2008; Takeda et al., 2008) and can mod-
ulate the activation of signal transduction pathways involved 
in cellular proliferation and differentiation (Sundaresan et al., 
1995; Sattler et al., 1999; Owusu-Ansah and Banerjee, 2009).
Although the current study highlights the importance of 
GPx3 in normal and leukemia hematopoiesis, the implication 
of ROS as the key modulator of GPx3 activity has not been 
established. This is particularly critical in the context that 
ROS scavenger (N-acetyl-l-cysteine treatment) and p38 in-
hibition failed to consistently increase LSC frequency of 
FLB1 leukemia in vivo (unpublished data). Nonetheless, our 
results indicate that in some conditions (Hoxb4 or Prdm16 
gain of function) Gpx3 expression may represent a converg-
ing pathway that determines the activity of normal and leu-
kemic stem cells.
MATERIALS AND METHODS
Mice. Donor C57BL/6:Pep3b (Ly5.1) and recipient C57BL/6 (Ly5.2) mice 
were bred and maintained as previously described (Kroon et al., 1998). Experi-
mental procedures were revised and approved by the University of Montreal 
animal ethics committee (Comité de Déontologie de l’Expérimentation sur les 
Animaux de l’Université de Montréal).
Human cells. AML tumor samples and normal marrow samples were ob-
tained from the Quebec Leukemia Cell Bank (Montreal, Quebec) and the 
Orthopedic Surgery Department of the University Hospital of Tours (Tours, 
France), respectively. All these cells were obtained according to approved 
protocols of the institutional review boards after informed consent. Patients 
were classified in three risk groups for cytogenetic and molecular abnormali-
ties (Mrózek et al., 2007).
Isolation of mouse hematopoietic cell subpopulations. Cells were first 
purified for Sca1 using magnetic activated cell sorting as per the manufacturer’s 
instructions (Miltenyi Biotec). Further antibody staining and sorting to 
purify the c-Kit+, lineage (CD45R, CD3, Gr-1, Ter119) population 
were performed as described previously (Okada et al., 1992). The LTR-
HSC from BM (c-Kit+LinSca1+CD150+CD48, KLS SLAM) or E14.5 
d.p.c. FL (CD150+CD48-Sca1+Mac1+ Lin, SLAM Sca+Mac+), and HSC/
progenitor cells (CD150+CD48-Lin) from BM were sorted using FACS-
Aria cytometer (BD).
Retroviral infection and transplantation. Infection and transplantation 
procedures were performed as previously described (Thorsteinsdottir et al., 
1999). Infection medium consisted of DMEM, 15% FCS, 100 ng/ml IL-11, 
50 ng/ml Flt-3 ligand, 100 ng/ml SF, 10 µg/ml ciprofloxacin (Serologicals), and 
6 µg/ml polybrene (hexadimethrine bromide; Sigma-Aldrich).
Methylcellulose cultures. Progenitor assays were plated and scored as pre-
viously described (Kroon et al., 1998).
Competitive repopulation unit enumeration assays. Stem cell quantifi-
cation assays were performed essentially as previously described (Antonchuk 
et al., 2001).
Fluorescence studies. The studies were performed with monoclonal anti-
bodies specific for the following: Sca-1 (D7), Mac1 (M1/70), and Gr-1 
(RB6-8C5; BD); kit (2B8), CD48 (HM48-1), and CD45R (RA3-6B2; 
eBioscience); and CD150 (TC15-12F12.2), B220 (30-F11), CD3 (17A2), 
CD11b (M1/70), and TER-119 (BioLegend). Staining with H2DCFDA 
was performed according to the manufacturer’s instructions (Invitrogen) 
using fresh, not purified leukemic cells immediately after BM harvest. 
The peak excitation wavelength for oxidized H2DCFDA was 488 nm, and 
emission was 525 nm. Flow cytometry and confocal analyses were performed 
engineered to overexpress genes associated with self-renewal 
such as Hoxb4, NA10HD, Klf10, and Prdm16 (Sauvageau et al., 
1995; Ohta et al., 2007; Deneault et al., 2009). In these trans-
duced cells, levels of Gpx3 expression increased 3.2- to 
19.2-fold compared with controls (Fig. 5 B).
We next infected BM HSC/progenitor cells with retro-
viruses carrying two different Gpx3 hairpins with the ability 
to achieve 95% Gpx3 knockdown (Fig. 5 C, left). Clono-
genic progenitor cell activity was not affected by this decrease 
in Gpx3 expression (Fig. 5 C, right), and there was no in-
crease in apoptosis in the shGpx3 cell population compared 
with shLuc controls (not depicted). shRNA-mediated Gpx3 
silencing, however, dramatically impeded the ability of trans-
planted HSC to repopulate the hematopoietic system of re-
cipient mice at early (8 wk) and late (39 wk) time points after 
transplantation (Fig. 5 D). We also transplanted the shGpx3- 
and shLuc-transduced 5-FU–derived BM cells and analyzed 
their ability to home in the BM 48 h after injection. These 
experiments showed no difference between homing abilities 
of shGpx3- and shLuc-transduced cells. Together, these re-
sults identify Gpx3 as a critical regulator of short- and long-
term repopulating (LTR) HSC.
In reciprocal gain-of-function experiments, BM HSC/
progenitor cells engineered to overexpress Gpx3 showed a 
marked competitive advantage over controls when trans-
planted after a 7-d ex vivo culture step (Fig. 5 E). Proviral 
integration analyses of six recipients confirmed polyclonal he-
matopoiesis (Fig. 5 F), thus ruling out the possibility of inser-
tional mutagenesis. Moreover, some mice (#2570 and #2571; 
Fig. 5 F) were reconstituted by the same clones, indicating 
that self-renewal occurred in vitro before transplantation. 
GFP+ Gpx3-transduced cells contributed to production of 
lymphoid and myeloid peripheral blood leukocytes at >30 wk 
after transplantation, confirming the multipotential nature of 
the reconstituting clones (Fig. 5 G). These mice were hema-
tologically normal and showed no evidence of myeloprolifer-
ation or leukemia. Together, these results indicate that Gpx3 
enhances HSC expansion ex vivo possibly through modu-
lation of self-renewal activity. Unfortunately, such gain- 
of-function experiments were not possible with our FLB1 
leukemia model as we have not yet identified the in vitro 
conditions that would allow their effective transduction.
In summary, identification of an antioxidant enzyme such 
as GPx3 acting as a stem cell activity factor in leukemia raises 
the possibility that other ROS scavenging systems have regu-
latory importance in other CSS. A low ROS level in breast 
CSCs has recently been associated with increased expression 
of Foxo1 and the glutathione biosynthesis genes Gss and Gclm 
(Diehn et al., 2009). In normal hematopoiesis, ROSlow HSCs 
have a higher self-renewal potential than ROShigh HSCs (Jang 
and Sharkis, 2007), whereas loss of ATM (ataxia telangiectasia 
mutated) or a FoxO transcription factor correlates with 
elevated ROS levels and limits self-renewal capacity of 
HSC during serial transplantations (Ito et al., 2004, 2006; 
Tothova et al., 2007). ROS can function as signaling mol-
ecules in several cell types (Finkel and Holbrook, 2000; 
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XhoI–EcoRI (Invitrogen) and subcloned into the LMP vector according to 
the manufacturer’s guidelines (Invitrogen). Confirmatory sequencing was 
performed on all cloned shRNAs: shGpx3 #5, 5-TGCTGTTGACAGT-
GAGCGCTTCTACACTTTCCTGAAGAACTAGTGAAGCCACA-
GATGTAGTTCTTCAGGAAAGTGTAGAATTGCCTACTGCCTC-
GGA-3; shGpx3 #6, 5-TGCTGTTGACAGTGAGCGCGCAGTATG-
CAGGCAAATATATTAGTGAAGCCACAGATGTAATATATTTGCCT-
GCATACTGCTTGCCTACTGCCTCGGA-3; and shLuc, 5-TGCT-
GTTGACAGTGAGCGCCGATATGGGCTGAATACAAATTAGTGAA-
GCCACAGATGTAATTTGTATTCAGCCCATATCGTTGCCTACTG-
CCTCGGA-3.
Apoptosis assay. Phosphatidylserine externalization was analyzed 4 d after 
retroviral infection by labeling GFP+ cells with annexin V–Alexa Fluor 
350 and propidium iodide. Flow cytometry analyses were performed using 
an LSRII cytometer.
Homing assay. After retroviral infection, Ly5.1+ cells were transplanted via 
tail vein injection into irradiated (1,600 cGy, 137 Cs gamma radiation) 
C57BL/6J (Ly5.2) mice. A small aliquot of cells was plated at this time in 
methylcellulose to assess the percentage of transduced CFCs in the inoculum 
(see Methylcellulose cultures). 4 d after transplant, recipient BM was har-
vested and the percentage of GFP+Ly5.1+ cells was assessed by flow cytome-
try with the acquisition of a minimum of 106 events (LSRII cytometer). BM 
was also plated in methylcellulose for later enumeration and scoring of GFP+ 
and GFP CFCs (see Methylcellulose cultures).
Statistical analyses. Statistical analyses were performed using Wilcoxon’s 
test. The level of significance was set at 0.05.
Online supplemental material. Fig. S1 shows representative images of 
spleens from recipients of FLA2 and FLB1 cells at 19 d after transplantation. 
Table S1 shows FLA2 gene expression profiling. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20102386/DC1.
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Genes not differentially expressed (qRT-PCR) in FLA2 and FLB1 leukemias. The following is a list of genes not differentially expressed (qRT-PCR) 
in FLA2 and FLB1 leukemias: Acin1, Al840826, Akt1, Angplt3, Angptl2, Asxl1, Asxl2, Atf4, Atp9a, B4galt5a, Baz1b, Bmi1, Bmp2, Bmp4, Bmp7, Bteb1, 
C77009, Casp8ap2, Cat, Cbfb, Cbx2, Cbx4, Cbx6, Cbx7, Cbx8, Cdk5rap1, Cebpa, Cebpb, Crebbp, Crem, Cse1l, Cxcr4, Dnmt3b, Dpm1, E2A, Eed, Egfr, Egr1, 
Epc2, Etv6, Ezh1, Ezh2, Foxo1, Foxo3a, Foxo4, Foxo6, Gata2, Gfi1, Gli1, Gli2, Gli3, Glrx, Glrx2, Gpx1, Gpx2, Gpx4, Gpx5, Gpx6, Gpx7, Gr1, H3f3b, 
Hoxa1, Hoxa2, Hoxa3, Hoxa4, Hoxa5, Hoxa6, Hoxa7, Hoxa9, Hoxa10, Hoxa11, Hoxa13, Hoxb1, Hoxb2, Hoxb3, Hoxb4, Hoxb5, Hoxb6, Hoxb7, Hoxb8, Hoxb9, 
Hoxb13, IgJ, Irx5, Jak1, Kcnm1, L3mbtl1, L3mbtl2, L3mbtl3, Lef1, Lnk, Lmo2, Mef2c, Meis1, Meis2, Meis3, Mel18, Met, Mtor, Myb, Ncl, Nfatc2, Nfat5, Notch1, 
Numb, Orpl16, Pard3, Pard6a, Pard6b, Pcgf6, Phc2, Phc3, Phf1, Prdm16, Prdx1, Prdx2, Prdx3, Prdx4, Prdx5, Prdx6, Prep1, Prep2, Prox1, Pten, Ptgis, Ptpn1, PU.1, 
Rae28, Rap1a, Rarb, Rela, Rest, Rnf2, Rng1, Rsp13, Runx1, Runx2, S6k1, Scmh1, Scml2, Sf1, Slc9a8, Smarcc1, Snail, Sod1, Sod2, Sod3, Spata2, Stat1, Stat2, 
Stat3, Stat4, Stat5a, Stat5b, Stat6, Stau1, Suz12, Tal1, Tcf4, Tgif, Tnrc6b, Trim2, Trim28, Trp53rk, Txn1, Txn2, Ube2v1, Wwp1, Xbp1, and Zfp313. None of 
the tested genes showed more than twofold differential expression between FLA2 and FLB1 leukemias.
Figure S1. representative images of spleens from recipients of Fla2 and FlB1 cells at 19 d after transplantation.(A)FLA2.(B)FLB1.Wright-
stainedspleentouchpreparationswereacquiredusingaDMIRB(Leica)microscopewithanHCXPLFluotarL40×/0.6numericapertureobjective(Leica)
andaRetigaEKIcamera(Q-Imaging).ImagesweretransformedintoTIFFfilesusingPhotoshop(version6.0;AdobeSystems).
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table S1. FLA2geneexpressionprofiling
Gene Probe set Fold change SAM score q-value
d %
LTR element 1456319_at 0.025 16.03 0.00
IgK-C 1427660_x_at 0.080 14.04 0.00
Grb10 1425458_a_at 0.129 10.47 0.00
Xist 1436936_s_at 0.003 10.15 0.00
cDNA BC005512 1435628_x_at 0.372 8.45 0.00
Xist 1427262_at 0.005 8.41 0.00
IgK-C 1452417_x_at 0.078 8.02 0.00
LTR (Mela) 1433438_x_at 0.006 6.95 0.00
IgK-C 1427455_x_at 0.083 6.64 0.00
LTR (Mela) 1456182_x_at 0.005 6.64 0.00
Fundc 1428316_a_at 33.542 26.93 0.00
Eif2s3y 1417210_at 34.849 19.35 0.00
Pttg 1438390_s_at 15.935 18.03 0.00
Cdk5rap1 1448626_at 4.805 16.39 0.00
SINE element 1427820_at 5.054 15.43 0.00
Ddx3y 1426438_at 17.615 14.51 0.00
Ddx3y 1452077_at 5.363 11.08 0.00
Mgp 1448416_at 2.363 10.84 0.00
Hypothetical protein NM_025791 1416628_at 2.050 10.30 0.00
Tfpi 1451791_at 3.059 9.18 0.00
Gpx3 1449106_at 2.146 9.11 0.00
Hist1h2bp 1427762_x_at 2.311 8.77 0.00
cDNA AK007099 1455692_x_at 2.838 7.22 0.00
Mtm 1454904_at 2.766 7.09 0.00
Fundc2 1460434_at 3.223 6.16 0.00
Ncam1 1426864_a_at 2.159 5.80 0.00
Fbp1 1448470_at 3.910 5.13 0.00
Slc40a1 1417061_at 2.183 5.02 0.00
Rps13 1415912_a_at 2.102 4.99 0.00
Hypothetical protein NM_026592.3 1416824_at 4.432 4.95 0.00
Zmynd11 1436153_a_at 2.068 4.86 0.00
RIKEN cDNA 1700097N02 gene 1436419_a_at 2.715 4.35 2.71
St6gal1 1420928_at 2.850 4.21 2.71
Bolddenotes16probesexhibitingsignificantchangesofsignalafterexcludingthesexchromosomegenes.Minimumfoldchange,2;numberofpermutations,100;numberof
neighborsforKNN,10;falsediscoveryrate,2.71%.
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